The importance of diagnostic testing in CLL
Deacetylase inhibitors: a novel class of drugs for immune system malignancies
Efficacy of first generation FLT3 inhibitors for AML
May the force be with you: the power of next-generation sequencing
Do CLL patients with mutated immunoglobulin receptors respond better to therapy?